ENTA - Enanta Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.20
DETAILS
HIGH:
$87.00
LOW:
$20.00
MEDIAN:
$54.00
CONSENSUS:
$48.20
UPSIDE:
245.52%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-03-11 | Vance Terry | director | A-Award | 20,000 | $14.17 | $283K |
| 2026-03-11 | Russell Lesley | director | A-Award | 20,000 | $14.17 | $283K |
| 2026-03-11 | Peterson Kristine | director | A-Award | 20,000 | $14.17 | $283K |
| 2026-03-11 | Hata Yujiro S | director | A-Award | 20,000 | $14.17 | $283K |
| 2026-03-11 | FOLETTA MARK G | director | A-Award | 20,000 | $14.17 | $283K |
| 2026-03-11 | CARTER BRUCE L A | director | A-Award | 20,000 | $14.17 | $283K |
| 2026-02-12 | Kieffer Tara Lynn | officer: Chief Product Strategy Officer | A-Award | 1,575 | -- | -- |
| 2026-02-12 | Rottinghaus Scott T. | officer: Chief Medical Officer | A-Award | 5,225 | -- | -- |
| 2026-02-12 | Luly Jay R. | director, officer: President and CEO | A-Award | 15,200 | -- | -- |
| 2026-02-12 | Rottinghaus Scott T. | officer: Chief Medical Officer | F-InKind | 3,413 | $14.25 | $49K |
| 2026-02-12 | Kowalsky Matthew Paul | officer: Chief Legal Officer | F-InKind | 1,902 | $14.25 | $27K |
| 2026-02-12 | Kieffer Tara Lynn | officer: Chief Product Strategy Officer | A-Award | 4,987 | -- | -- |
| 2026-02-12 | Kieffer Tara Lynn | officer: Chief Product Strategy Officer | F-InKind | 3,257 | $14.25 | $46K |
| 2026-02-12 | Rottinghaus Scott T. | officer: Chief Medical Officer | A-Award | 1,650 | -- | -- |
| 2026-02-12 | Or Yat Sun | officer: Chief Scientific Officer | A-Award | 5,225 | -- | -- |
| 2026-02-12 | Or Yat Sun | officer: Chief Scientific Officer | F-InKind | 3,413 | $14.25 | $49K |
| 2026-02-12 | Or Yat Sun | officer: Chief Scientific Officer | A-Award | 1,650 | -- | -- |
| 2026-02-12 | Luu Brendan | officer: Chief Business Officer | A-Award | 4,987 | -- | -- |
| 2026-02-12 | Luu Brendan | officer: Chief Business Officer | F-InKind | 3,257 | $14.25 | $46K |
| 2026-02-12 | Luu Brendan | officer: Chief Business Officer | A-Award | 1,575 | -- | -- |
| 2026-02-12 | Luly Jay R. | director, officer: President and CEO | F-InKind | 6,155 | $14.25 | $88K |
| 2026-02-12 | Kowalsky Matthew Paul | officer: Chief Legal Officer | A-Award | 4,175 | -- | -- |
| 2026-02-12 | Kowalsky Matthew Paul | officer: Chief Legal Officer | A-Award | 1,318 | -- | -- |
| 2026-02-12 | Luly Jay R. | director, officer: President and CEO | A-Award | 4,800 | -- | -- |
| 2025-12-05 | Capps Kathleen S. | officer: See Remarks | SELL | 323 | $14.23 | $5K |